期刊文献+

大剂量促红细胞生成素治疗肾性贫血的疗效观察 被引量:2

下载PDF
导出
摘要 目的:观察大剂量促红细胞生成素治疗肾性贫血的疗效。方法:选择慢性肾功能不全肾性贫血患者,观察组采用大剂量促红细胞生成素(沈阳三生制药公司生产的益比奥)10000U皮下注射1次/周;对照组:使用促红细胞生成素3000U(同为该厂生产的益比奥)皮下注射2~3次/周,观察治疗期间的Hb、Hct、RBC及不良反应。结果:观察组显效13例,有效7例,无效3例,对照组显效11例,有效8例,无效4例。结论:大剂量促红细胞生成素每周1次与常规剂量促红细胞生成素每周2~3次治疗肾性贫血的疗效和不良反应,差异无显著性,但减少了注射次数,提高了患者的依从性。
出处 《现代医药卫生》 2007年第16期2408-2409,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献3

二级参考文献16

  • 1[1]Bergrem H, Danielson BG, Eckardt KU, et al. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment.Erythropoietin : molecular physiology and clinical applications. New York: Marcel Dekker, 1993, 266-275
  • 2[2]Wikstrom B, Goch J, Danielson BG, et al. Serum erythropoietin in renal transplant patients. Transplant Proc, 1989,21 ( 1 Pt 2) :2043 - 2045
  • 3[3]MilledgeJS, Cotes PM. Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol, 1985, 59(2) :360-364
  • 4[6]Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.J Pediatr, 1988,113(6):1015- 1021
  • 5[7]Muirhead N, Hodsman AB, Hollomby DJ, et al. The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant, 1991,6(5) :342 - 345
  • 6[8]Maeda Y, Sakaguchi M, Naiki Y, etal. Possible involvement of soluble erythropoietin receptor in resistance to erythropoietin in patients with renal anemia. Am J Nephrol, 2001,21(5) :426
  • 7[9]Carozzi S, Nasini MG, Santoni O, et al. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis. ASAIO J, 1997,43(5): M535 - 538
  • 8[10]Movilli E, Cancarini GC, Zani R, et al. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients. Nephrol Dial Transplant, 2001,16(1) :111 - 114
  • 9[11]Casedevall N, Nataf J, Viron B, et al. Pure red - cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med, 2002,346(7): 469-478
  • 10[13]Castelli G, Famularo A, Semino C, et al. Detection of anti - erythropoietin antibodies in haemodialysis patients treated with recombinant human- erythropoietin. Pharmacol Res, 2000, 41(3): 313-318

共引文献71

同被引文献23

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部